- +267.1% price growth over the last year
- High gross margin of 94.0%
- Low bankruptcy risk (Altman Z-Score: 4.32)
Stronger technical forecast for Travere Therapeutics, Inc. stock price after Tuesday trading
(Updated on Jun 23, 2026)
The Travere Therapeutics, Inc. stock price gained 1.52% on the last trading day (Tuesday, 23rd Jun 2026), rising from $55.11 to $55.95. During the last trading day the stock fluctuated 3.46% from a day low at $54.13 to a day high of $56.01. The price has risen in 7 of the last 10 days and is up by 18.84% over the past 2 weeks. Volume fell on the last day by -161 thousand shares and in total, 2 million shares were bought and sold for approximately $88.49 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 65.49% during the next 3 months and, with a 90% probability hold a price between $80.01 and $100.52 at the end of this 3-month period.
TVTX Signals & Forecast
Mostly positive signals in the chart today. The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $54.22 and $46.81. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 30.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock
Travere Therapeutics, Inc. finds support from accumulated volume at $55.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.88 between high and low, or 3.46%. For the last week, the stock has had daily average volatility of 3.59%.
The Travere Therapeutics, Inc. stock is extremely overbought on RSI14 (85). This increases the short-term risk substantially.
Our recommended stop-loss: $54.38 (-2.80%) (This stock has high daily movements and this gives high risk. The RSI14 is 85 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)
Trading Expectations (TVTX) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Travere Therapeutics, Inc. to open at $55.36, and during the day (based on 14 day Average True Range), to move between $54.81 and $57.09, which gives a possible trading interval of +/-$2.27 (+/-4.15%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.15% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $55.15, some $0.80 (1.43%) from the current price of $55.95, our system finds the risk reward attractive.
Is Travere Therapeutics, Inc. stock A Buy?
Travere Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
6.932
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $55.36 ( 1.05%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TVTX Performance
Trading levels for TVTX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 57.24 | 2.30% |
| R2 | 56.52 | 1.02% |
| R1 | 56.08 | 0.229% |
| Price | 55.95 | |
| S1 | 54.65 | -2.33% |
| S2 | 54.20 | -3.12% |
| S3 | 53.49 | -4.40% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 55.95 | |
| S1 | 55.15 | -1.43% |
| S2 | 42.66 | -23.75% |
| S3 | 42.13 | -24.70% |
FAQ
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.
Buy TVTX